EB病毒LMP1在鼻咽癌细胞中通过NFκB促进Igκ表达

利用已建立的受四环素调控ＬＭＰ１表达的鼻咽癌细胞系,用受ＣＭＶ启动子调控的ＮＦκＢ报道基因质粒ｐＮＦκＢ－ｌｕｃ的荧光素酶表达分析ＮＦκＢ的活性,并以核蛋白的Ｗｅｓｔｅｒｎ印迹方法观察ＬＭＰ１表达前后核内ＮＦκＢ组分ｐ６５量的改变,用全蛋白Ｗｅｓｔｅｒｎ印迹分析Ｉｇκ蛋白质的表达等方法,探讨在鼻咽癌中,ＥＢ病毒ＬＭＰ１蛋白是否通过核转录因子ＮＦκＢ促进免疫球蛋白κ轻链（Ｉｇκ）基因的表达。结果显示     

地高辛标记反意RNA探针检测脑组织切片生长抑素mRNA

本实验采用含大鼠生长抑素基因的ｐＳＰ６５ｃＤＮＡ质位通过转化至噬菌体内大量扩增,经提取,纯化后,用限制性内切酶进行酶切使质枝线性化,并将其作为模板,用地高辛（ＤｉｇｏｘｉｇｅｎｉｎＤｉｇ）作为标记物,体外转录合成生长抑素反意ＲＮＡ（ｃＲＮＡ）探针。实验动物选用ｗｉｓｔａｒ新生大鼠。冰冻切片,端、间脑切片经杂交前用Ｄｉｇ－ＵＴＰ标记的ｃＲＮＡ探针杂交,杂交后用抗Ｄｉｇ－碱性磷酸酶复合物进行酶联免疫反应。Ｘ－磷酸盐－ＮＢＴ显色。结果显示新生大鼠脑内生长抑素ｍＲＮＡ神经元着紫蓝色。杂交反应物集中于核周的胞浆及短小的突起内。胞核不着色。胞体轮廓清晰,周围背底浅淡。结果表明Ｄｉｇ标记ｃＲＮＡ探针不仅具备非同位素标记探针的优点而且能快速和准确检测组织细胞内ｍＲＮＡ的表达。     

真核生物mRNA的帽结构与帽结合蛋白

帽结构是所有ＲＮＡ 聚合酶Ⅱ转录产物的特征性结构,它在ｍ ＲＮＡ 的功能和代谢的很多方面起作用． 在这些过程中还离不开相关蛋白质对它的识别和粘附,作为它行使功能的媒介,这些蛋白质就称为帽结合蛋白（Ｃａｐ－Ｂｉｎｄｉｎｇ Ｐｒｏｔｅｉｎ,ＣＢＰ）． 该文主要讨论了帽结构与胞质中的ＣＢＰ－ｅＩＦ４Ｅ（ｅｕｋａｒｙｏｔｉｃ ｉｎｉｔｉａｔｉｏｎ ｆａｃｔｏｒ ４Ｅ,真核起始因子４Ｅ）的相互作用在ｍ ＲＮＡ 指导的翻译起始中的作用机制,以及帽结构与核内发现的另一种ＣＢＰ复合体相互作用在ｍ ＲＮＡ 加工中的作用．     

ELISA法和PCR技术检测孕妇风疹病毒感染的研究

对８７２例孕妇风疹病毒ＩｇＭ检测,结果阳性４１例,阳性率为４．７％;对ＩｇＭ阳性者进一步用ＰＣＲ检测风疹病毒ＲＮＡ,其中１９例阳性,占ＩｇＭ阳性的４６．３４％。风疹病毒感染与孕龄、职业无关,与孕次有关（χ２＝８．９４,Ｐ＜０．０５）,与不良孕产史有密切关系（χ２＝４．７４,Ｐ＜０．０５）。     

用人工合成的丁型肝炎病毒抗原多肽检测丁肝病毒IgM抗全及其初步应用

用人工合成的丁型肝炎病毒抗原（ＨＤＶ－Ａｇ）肽建立了检测抗ＨＤＶ－ＩｇＭ抗体的ＥＬＩＳＡ方法。本法操作简便、快速、重复性好、特异性强,与抗ＨＡＶ－ＩｇＭ＇抗ＨＢｃ－ＩｇＭ、抗ＨＢｓ－ＩｇＭ、抗ＨＣＶ－ＩｇＭ、抗ＣＭＶ－ＩｇＭ、抗ＲＶ－ＩｇＭ、类风湿因子（ＲＦ）及抗核抗体（ＡＮＡ）阳性血清均不起反应,且可被２－巯基乙醇阻断而不起反应。经初步临床应用,３１例正常人血清抗ＨＤＶ－ＩｇＭ全部阴性,２８例慢     

雄激素受体在肝癌发生过程中的表达及意义

为了进一步探讨雄激素受体（ＡｎｄｒｏｇｅｎＲｅｃｅｐｔｏｒ,ＡＲ）作为肝癌标志物的意义,本文采用免疫组织化学ＡＢＣ法,对二乙基亚硝胺（ＤＥＮ）诱发大鼠肝癌发生过程中肝细胞雄激素受体（ＡＲ）的表达进行了系统观察。结果显示：正常大鼠的ＡＲ阳性肝细胞极少,ＤＥＮ诱癌第４周可见少量肝细胞呈ＡＲ阳性表达,细胞散在分布,胞质和／或胞核内可见棕褐色阳性反应颗粒。随着肝癌发展进程,ＡＲ阳性肝细胞数逐渐增多,呈簇状或片状分布。至诱癌第１８周,肝癌结节内肝癌细胞大多呈ＡＲ阳性表达。本实验结果表明,ＡＲ与肝癌的发生和发展具有密切关系     

激光共聚焦显微镜研究大白鼠肝癌FSK7902细胞系的实体瘤中角蛋白和嗜铬颗粒素A的关系

应用免疫组织化学ＡＢＣ法和免疫荧光组织化学方法结合激光共聚焦显微镜观察了嗜铬颗粒素Ａ和角蛋白在大白鼠肝癌ＦＳＫ７９０２细胞系形成的实体瘤癌细胞中的表达,结果表明在ＦＳＫ７９０２实体瘤内,大多数癌细胞呈角蛋白和ＣｇＡ免疫反应阳性,反应产物位于核周胞质或核旁的某些区域。     

cDNA克隆p14－6肿瘤抑制功能的分子机制

本文探讨了具有肿瘤抑制功能的ｃＤＮＡ克隆Ｐ１４－６（即人白细胞介素６核转录因子ＮＦ－ＩＬ６的３’非翻译区）的ＲＮＡ转录物与回复相关蛋白ＢＮＦ的相互作用,发现该ＲＮＡ与ＢＮＦ的相互作用位点为其３’侧的富Ｕ序列内的１个２４核苷酸片段;并发现ＢＮＦ系一群蛋白质,它们可能先相互结合成１个蛋白质复合物,然后再与ＲＮＡ位点作用．其中可能只有１个蛋白质（Ｒ６２）直接与该ＲＮＡ结合。     

ELISA法和PCR技术检测孕妇风疹病毒感染的研究

对８７２例孕妇风疹病毒ＩｇＭ检测,结果阳性４１例,阳性率为４．７％,对ＩｇＭ阳性者进一步用ＰＣＲ检测风疹病毒ＲＮＡ,其中１９例阳性,占ＩｇＭ阳怀的４６．３４％,风疹病毒感染与孕龄,职业无关,与孕次有关,与不良孕产史有密切关系。     

RNA聚合酶Ⅲ启动子的结构与功能

ＲＮＡ聚合酶Ⅲ (ｐｏｌⅢ )是真核生物催化合成ｔＲＮＡ和 5ＳｒＲＮＡ及一些核小ＲＮＡ和胞质ＲＮＡ必需的酶。ＲＮＡ聚合酶Ⅲ能够识别ｔＲＮＡ基因中一些高度保守的特征性ＤＮＡ序列而启动下游ＤＮＡ的转录 ,这些序列称为ＲＮＡ聚合酶Ⅲ启动子。ＲＮＡ聚合酶Ⅲ启动子不仅广泛存在于真核细胞中ｔＲＮＡ、Ｕ6核小ＲＮＡ(ＳＮＲ6 )等的基因中 ,也是病毒催化合成一些小片段ＲＮＡ如腺病毒ＶＡＲＮＡ所必需的。ＲＮＡ聚合酶Ⅲ启动子因其能在体内外高效快速地转录某些小片段基因 ,已被人们广泛地应用于核酶和反义ＲＮＡ技术中 ,在众多的ＲＮＡ…     

Cell surface antigens expressed by subsets of pre-B cells and B cells

A large number of monoclonal antibodies, produced by immunizing rats with mouse pre-B cell lines, have been analyzed for their ability to define cell surface antigens expressed by B cells at early stages of differentiation. Whereas many antibodies recognized antigens on pre-B cell lines, only two clones detected cell surface antigens that were distinguished by their restricted distribution among a panel of continuous cell lines and cells from various tissues. Monoclonal antibody clone AA4.1 recognized a cell surface antigen found on all pre-B lymphomas and on one of three B lymphomas tested. This antigen was found on cells at highest frequency in the bone marrow. Adult spleen and fetal liver also have detectable numbers of AA4.1+ cells. Cells that did not express this antigen include plasmacytomas, two of three B lymphomas, T lymphomas, a stem cell line, adult liver, brain, thymus, and lymph node cells. Clone GF1.2 detected an antigen on some pre-B cell lines, one of three B lymphomas tested, and a small fraction of cells from adult bone marrow, spleen, lymph node, and fetal liver. Plasmacytomas, some pre-B lymphomas, two B lymphomas, T lymphomas, adult liver, brain, and thymus cells were negative. In adult bone marrow, AA4.1 bound to all cytoplasmic IgM+ pre-B cells, whereas GF1.2 detected one-half of these cells. Both antibodies recognized approximately 50% of surface IgM+ (sIgM+) bone marrow cells. A small population of bone marrow cells lacking any detectable Ig (surface or cytoplasmic) also reacted with these antibodies. Depletion of AA4.1 or GF1.2 antigen-bearing cells from bone marrow reduced the ability of bone marrow B cells to respond to LPS by 50 to 65%. Experiments with a cloned pre-B lymphoma demonstrate that AA4.1+ pre-B cells become sIgM+ GF1.2+ B cells after activation with LPS. These antibodies recognize cell surface determinants with restricted distribution among the B lymphocyte lineage because they detect antigens displayed by normal and transformed immature B lymphocytes.     

CD44 co-stimulates apoptosis in thymic lymphomas and T cell hybridomas

Thymic lymphomas and hybridomas vary in their sensitivity to dexamethasone (DEX). Identical variance has been demonstrated in our laboratory for apoptosis of such cells by primary thymic epithelial cells or a cell line (TEC). We have also shown that apoptosis induced by TEC was partially mediated by TEC-derived glucocorticoids (GC). We studied the responses of various thymic lymphomas and hybridomas to TEC and DEX. Of these cells, PD1.6 and 2B4 were sensitive whereas B10 were relatively resistant to either inducer. In the present study we found that TEC and DEX synergize in inducing B10 cell apoptosis. B10 cells could also undergo apoptosis by TEC, conditional upon the presence of a TEC-sensitive cell (PD1.6 or 2B4). Contact between TEC and B10 was essential for apoptosis to occur. Thus, TEC may provide two signals, one mediated by GC and the other requiring cell to cell contact. We then analyzed the involvement of co-stimulatory or adhesion molecules in the TEC-induced apoptosis of thymic lymphoma cells. Soluble anti-CD44 antibodies but not anti-CD18, CD2 or CD28, inhibited TEC-induced apoptosis of PD1.6. Dimerization of CD44 by immobilized antibodies augmented DEX-induced apoptosis of all the lymphomas tested. CD44 cross-linkage up-regulated expression of the pro-apoptotic protein Bax, and down-regulated the anti-apoptotic protein, Bclx(L), in the presence of DEX. Taken together, the data suggest that CD44 enhances the apoptotic response of T lymphoma cells to DEX, and that CD44 modulates TEC-induced apoptosis of thymic lymphomas.     

Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties

Interferon regulatory factor 7 (IRF-7) is implicated in the regulation of Epstein-Barr virus (EBV) latency. EBV transforms primary B cells, and the major EBV oncoprotein, latent membrane protein 1 (LMP-1), is required for the process. LMP-1 both induces the expression of IRF-7 and activates the IRF-7 protein by phosphorylation and nuclear translocation. Here we report that the expression of IRF-7 is increased in EBV-immortalized B lymphocytes compared with that in primary B cells. IRF-7 was phosphorylated and predominantly localized in the nucleus in the immortalized cells. The expression of IRF-7 was detected in 19 of 27 specimens of primary lymphomas of the human central nervous system by immunohistochemical analysis. The association between LMP-1 and IRF-7 was statistically highly significant for these specimens. An appreciable amount of the IRF-7 expressed in lymphoma cells was localized in the nucleus. Furthermore, IRF-7 promoted the anchorage-independent growth of NIH 3T3 cells. LMP-1 and IRF-7 showed additive effects on the growth transformation of NIH 3T3 cells. IRF-7-expressing NIH 3T3 cells formed tumors in athymic mice. Thus, IRF-7 has oncogenic properties and, along with LMP-1, may mediate or potentiate the EBV transformation process in the pathogenesis of EBV-associated lymphomas.     

Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France

The term “gray-zone” lymphoma has been used to denote a group of lymphomas with overlapping histological, biological, and clinical features between various types of lymphomas. It has been used in the context of Hodgkin lymphomas (HL) and non-Hodgkin lymphomas (NHL), including classical HL (CHL), and primary mediastinal large B cell lymphoma, cases with overlapping features between nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B cell lymphoma, CHL, and Epstein–Barr-virus-positive lymphoproliferative disorders, and peripheral T cell lymphomas simulating CHL. A second group of gray-zone lymphomas includes B cell NHL with intermediate features between diffuse large B cell lymphoma and classical Burkitt lymphoma. In order to review controversial issues in gray-zone lymphomas, a joint Workshop of the European Association for Hematopathology and the Society for Hematopathology was held in Bordeaux, France, in September 2008. The panel members reviewed and discussed 145 submitted cases and reached consensus diagnoses. This Workshop summary is focused on the most controversial aspects of gray-zone lymphomas and describes the panel’s proposals regarding diagnostic criteria, terminology, and new prognostic and diagnostic parameters.     

Immunologic induction of malignant lymphoma: graft-vs-host reaction-induced B cell lymphomas contain integrations of predominantly ecotropic murine leukemia proviruses

The induction of a graft-vs-host reaction in (BALB/c X A)F1 mice by i.v. injection with BALB/c lymphoid cells leads to a lymphoid hyperplasia that may progress to malignant lymphoma. In the present paper, the following aspects of graft-vs-host-reaction lymphomagenesis were studied: 1) the cellular requirements for the induction of lymphomas, 2) their cellular origin, and 3) the role of murine leukemia viruses. The development of graft-vs-host-reaction lymphomas was found to be mediated by donor T cells and to require the presence of histoincompatibility between donor and host. Histologically, the vast majority of these lymphomas were either of follicular center cell or of immunoblastic type, whereas immunoperoxidase studies showed that they were virtually all B cell derived. Most of the lymphomas were of host origin. In the DNA of approximately 80% of the lymphomas, integrated murine leukemia virus proviruses were detected. In the B cell lymphoma DNA, integrated ecotropic proviruses prevailed, but recombinant murine leukemia virus and/or deleted murine leukemia virus genomes were also detected in some tumor DNA.     

Differentiation antigens on normal and Abelson virus transformed lymphocytes.

Rabbit antisera to Abelson leukemia virus (A-MuLV)-induced murine lymphomas have been analyzed by absorption with a variety of murine lymphoma lines. Antibody binding to a panel of cell lines and normal lymphocytes was visualized by using hapten-sandwich indirect membrane immunofluorescence. Novel membrane antigens thereby detected are shared between lymphosarcomas, B lymphomas, normal B lymphocytes, and normal membrane immunoglobulin negative (sIg-) bone marrow cells, but are not found on T cells, thymic lymphomas, plasmacytoid lymphomas, or myelomas. The existence of such shared differentiation antigens suggests that sIg- A-MuLV-induced lymphosarcomas may be transformed B cell precursors. Since differences in the expression of these antigens on individual plasma-cytoid lymphoma lines were found, this category of lymphomas may include cells at a variety of differentiation states.     

Induction of lymphomas on implantation of human oral squamous cell carcinomas in nude mice

Cancer cells from five oral cancer patients and pleomorphic adenoma cells from one individual were inoculated as single cell suspension into subcutis of 30 Swiss nude mice and tail vein of additional 30 mice. Further, tumor tissue pieces from three oral cancer patients were xenografted s.c. in 18 nude mice, and 10 mice were kept as controls. In animals implanted with tumor pieces, 7/18 (39%) mice, developed squamous cell carcinoma at the site of inoculation within 8-15 days, while tumors were not observed in mice inoculated with single cell suspension, up to 60/90 days. In 8/68 (12%) mice, white foci were observed in several tissues, with hepatomegaly and splenomegaly noted in 27/68 (39%) mice. Histopathological examination of various tissues revealed presence of large cell lymphoma in several organs in 14/68 (21%) mice. No regional or distant metastasis of the implanted oral tumor cells was detected. Mice injected with cells from pleomorphic adenoma, also demonstrated large cell lymphoma in 2/10 (20%) mice, whereas none of the 10 control animals showed any gross abnormalities or microscopic abnormalities in several organs. 2/16 (12%) lymphomas exhibited positive reaction with mouse B cell antibodies illustrating the murine origin of the lymphomas, and these were immunophenotyed as B cell lymphomas. The lymphomas were also examined with mouse T cell antibodies and none reacted positively with the mouse T cell antibodies. The lymphomas also failed to react with human T cell, B cell and human Leucocyte common antigen (LCA) antibodies, indicating that the induced lymphomas were not of human origin. The tumor specimens from seven of eight oral cancer patients and the pleomorphic adenoma patient induced lymphomas in nude mice. Thus it appears that xenografting oral tumor cells into nude mice may cause induction of the murine lymphomas, and this needs further investigation.     

Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage

Constitutive activation of FGFR1, through rearrangement with various dimerization domains, leads to atypical myeloproliferative disorders where, although T cell lymphoma are common, the BCR-FGFR1 chimeric kinase results in CML-like leukemia. As with the human disease, mouse bone marrow transduction/transplantation with BCR-FGFR1 leads to CML-like myeloproliferation as well as B-cell leukemia/lymphoma. The murine disease described in this report is virtually identical to the human disease in that both showed bi-lineage involvement of myeloid and B-cells, splenomegaly, leukocytosis and bone marrow hypercellularity. A CD19(+) IgM(-) CD43(+) immunophenotype was seen both in primary tumors and two cell lines derived from these tumors. In all primary tumors, subpopulations of these CD19(+) IgM(-) CD43(+) were also either B220(+) or B220(-), suggesting a block in differentiation at the pro-B cell stage. The B220(-) phenotype was retained in one of the cell lines while the other was B220(+). When the two cell lines were transplanted into syngeneic mice, all animals developed the same B-lymphoblastic leukemia within 2-weeks. Thus, the murine model described here closely mimics the human disease with bilineage myeloid and B-cell leukemia/lymphoma which provides a representative model to investigate therapeutic intervention and a better understanding of the etiology of the disease.     

Termination of the B cell lymphoma dormant state in thymectomized AKR mice.

AKR mice are highly susceptible to spontaneous T cell lymphomagenesis and thymus removal at the age of 1 to 3 mo greatly reduces its development. Twelve-mo-old AKR mice thymectomized at young age were shown previously to carry potential lymphoma cells that could be triggered to develop into B cell lymphomas (80 to 100%) after removal from their host "restrictive" environment into young histocompatible hosts. Additional attempts were made to terminate the potential lymphoma cell dormant state in 12-mo-old thymectomized AKR mice. Replenishment of some deficiencies caused by thymectomy at a young age, including a s.c. syngeneic thymus graft or a single injection of the dual tropic recombinant virus isolates DTV-71 or MCF-247 into 12-mo-old thymectomized AKR mice resulted in Ly-1+ pre-B or B cell lymphoma development in 80 to 98% of these treated mice. In vivo elimination of T cell subsets by administration of cyclosporin A or by mAb expressed on Th cells (anti-CD4) or cytotoxic T cells (anti-CD8) stimulated the progression of dormant potential lymphoma cells towards B cell lymphoma development. The most striking results were observed after administration of anti-CD8 mAb: 90 to 100% of these treated mice developed Ly-1+ B cell lymphomas within 80 days. The effect of rIL-2 on dormant PLC was also tested. Administration of rIL-2 to 12-mo-old thymectomized mice terminated tumor dormancy in 94% of the treated mice within 66 days. Tests of the resulting B lymphomas for dual tropic recombinant virus/mink cell focus-inducing virus infection indicated that the breakdown of tumor dormancy did not result from development of pathogenic class I mink cell focus-inducing viruses. These results suggest that T cell subsets and/or their products are involved in the proliferation arrest of potential lymphoma cells present in thymectomized AKR mice.